Table 1 Neutralization EC50 of 32D6 against H1N1 clinical isolates before or after the 2009 pandemic.
From: An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells
Clinical isolates before 2009 pandemic | Genotype | EC50 (μg/mL) |
|---|---|---|
2006-INF-00923 | A/Solomon Islands/3/2006 | >50 |
2007-INF-01180 | A/New Caledonia/20/99 | >50 |
2007-INF-00125 | A/Brisbane/59/2007 | >50 |
2009-INF-00447 | A/Brisbane/59/2007 | >50 |
2009-INF-00479 | A/Brisbane/59/2007 | >50 |
2009-INF-00480 | A/Brisbane/59/2007 | >50 |
Clinical isolates after 2009 pandemic | ||
A/Taiwan/80813/2013 | A/California/07/2009 | 0.036 |
2013-INF-152 | A/California/07/2009 | 0.014 |
2013-INF-153 | A/California/07/2009 | 0.005 |
2014-INF-36 | A/California/07/2009 | 0.011 |
2014-INF-37 | A/California/07/2009 | 0.012 |
